The Pharma Letter1d
pharma&’s Rubraca recommended by NICE
Privately-held Austria firm pharmaand GmbH (pharma&) today announced that the National Institute of Health and Care Excellence (NICE) has issued a positive recommendation for its Rubraca (rucaparib).
Business Wire3d
Deep Track Capital Nominates Four Highly Qualified Candidates for Election to Dynavax Technologies’ Board of Directors at 2025 Annual Meeting
Deep Track Capital, LP, (together with its affiliates, “Deep Track” or “we”), one of the largest shareholders of Dynavax Technologies Corporation (NAS ...
Inside the final hours of Luke Williams' Swansea City reign and the man who could throw his hat in the ring
The Irishman threw his hat into the ring to get the job permanently back then. It's not beyond the realms of possibility he ...
NHS warns that 'pins and needles' could lead to 'irreversible' health issues
However, alarmingly it could also be a sign of a significant deficiency. The NHS has revealed that having pins and needles ...
Barington Capital Reminds Matthews International Shareholders to Cast Their Vote for Independent, Fresh Perspectives in the Boardroom
Barington Capital Group, L.P. ("Barington Capital"), a fundamental, value-oriented activist investor that, together with the other participants in its solicitation (collectively "Barington" or "we"), ...
Yahoo Finance3d
Deep Track Capital Nominates Four Highly Qualified Candidates for Election to Dynavax Technologies’ Board of Directors at 2025 Annual Meeting
Issues Letter to Fellow Shareholders Detailing Why Truly Independent Voices – Including a Shareholder Representative – Are Needed in the Dynavax Boardroom Highlights Concerns that Company’s ...